Taysha Gene Therapies, Inc. TSHA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $7.47M+3.4% | $9.77M+17.3% | $6.31M-36.4% | $8.1M-37.1% | $7.22M-49.0% | ||
| $104.65M+71.8% | $86.4M+30.9% | $76.78M+21.2% | $65.98M+9.6% | $60.91M-6.2% | ||
| $35.39M+17.9% | $33.87M+17.0% | $31.66M+9.0% | $31.29M+5.2% | $30.03M+5.8% | ||
| $140.03M+46.2% | $120.27M+20.5% | $108.44M+11.0% | $102.1M+12.2% | $95.77M+1.5% | ||
| -$132.56M-49.7% | -$110.5M-20.8% | -$102.13M-16.4% | -$94M-20.3% | -$88.55M-10.4% | ||
| -1,774.4%-549pp | -1,130.6%-33.1pp | -1,618.5%-733pp | -1,160.8%-554pp | -1,225.8%-659pp | ||
| $53K-42.4% | $63K-38.2% | $73K-90.8% | $82K-96.3% | $92K-97.5% | ||
| $2.69M+50.6% | $1.5M-30.4% | $2.2M— | $1.28M— | $1.78M— | ||
| -$129.88M-49.7% | -$109M-22.1% | -$99.93M— | -$92.72M— | -$86.77M— | ||
| -1,738.4%-537pp | -1,115.3%-43.6pp | -1,583.7%— | -1,145%— | -1,201.1%— | ||
| -$0.38-11.8% | -$0.34+5.6% | -$0.33— | -$0.34— | -$0.34— | ||
| -$131.47M-50.5% | -$109.42M-21.3% | -$101.04M-16.8% | -$92.82M-20.8% | -$87.36M-10.8% | ||
| -1,759.7%-550pp | -1,119.6%-36.8pp | -1,601.3%-729pp | -1,146.2%-549pp | -1,209.3%-653pp | ||
| -$132.56M-49.7% | -$110.5M-20.8% | -$102.13M-16.4% | -$94M-20.3% | -$88.55M-10.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Taysha Gene Therapies, Inc.'s revenue?
- Taysha Gene Therapies, Inc. (TSHA) generated $7.5M in revenue over the trailing twelve months, up 3.4% year over year.
- Is Taysha Gene Therapies, Inc. profitable?
- Taysha Gene Therapies, Inc. is not currently profitable: it reported a net loss of $129.9M over the trailing twelve months, a -1738.4% net margin.
- What is Taysha Gene Therapies, Inc.'s earnings per share?
- Taysha Gene Therapies, Inc.'s diluted EPS over the trailing twelve months is $-0.38.
- Where does Taysha Gene Therapies, Inc.'s income statement data come from?
- Every line is extracted from Taysha Gene Therapies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
